Page 5 - Multiplex Assay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CDC to Replace Its PCR Test With One That Can Differentiate Between CCP Virus and Flu Posted on The Centers for Disease Control and Prevention (CDC) will no longer recommend its PCR test to detect the CCP virus, saying that it will withdraw the test’s emergency use authorization (EUA), and instead, encourage labs to use a multiplex assay that can detect and differentiate the virus from the flu. “Given the availability of commercial options, CDC intends to discontinue support for the CDC 2019 Novel Coronavirus (2019 nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in Fe...

Promega Corporation: SARS-CoV-2 Antibody Test Developed by Promega Receives CE Mark Novel bioluminescent Lumit Dx SARS-CoV-2 Immunoassay enables simple, scalable antibody detection A SARS-CoV-2 antibody test developed by Promega Corporation, the Lumit Dx SARS-CoV-2 Immunoassay, has received CE marking and is now available in Europe. The novel bioluminescent immunoassay is a qualitative in vitro diagnostic test intended to detect antibodies to SARS-CoV-2 in serum. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210609005062/en/ The L...

Search jobs Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020. “We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder...

Combined CDC COVID-19/Influenza Test Amended to Include Promega Maxwell® RSC 48 and CSC 48 Instruments, Maxwell® RSC Viral Total Nucleic Acid Purification Kit on January 14 2021 1:00 AM Expanded list of authorized instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay MADISON, Wis.--(BUSINESS WIRE)--#COVID19--Labs performing the Centers for Disease Control’s (CDC) Flu SC2 Multiplex Assay, a single test to diagnose infection caused by SARS-CoV-2, influenza A, or influenza B, can now use two Promega instruments and a Promega nucleic ...

(0) Expanded list of authorized instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay Labs performing the Centers for Disease Control's (CDC) Flu SC2 Multiplex Assay, a single test to diagnose infection caused by SARS-CoV-2, influenza A, or influenza B, can now use two Promega instruments and a Promega nucleic acid purification kit in the protocol. In a letter dated January 8, 2021, the US Food and Drug Administration (FDA) authorized an amendment to the Emergency Use Authorization (EUA) for the CDC Influenza SARS-CoV-2 (Flu SC2) Mult...